🇺🇸 FDA
Pipeline program

Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

SYSKY-2025-397-01

Unknown small_molecule active

Quick answer

Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab for Breast Cancers is a Unknown program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).

Program details

Company
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Indication
Breast Cancers
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials